Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
Location status: Recruiting
NCT Number: NCT04160715
This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.
Interested in participating?
Request Info30 year–100 year
All sexes
Observational
Seongnam-si, 13620, South Korea
Location status: Recruiting
Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 1 year
lung function change (FVC, DLCO)
Time frame: through study completion, an average of 1 year
death rate
Time frame: through study completion, an average of 1 year
rate of acute exacerbation
Time frame: through study completion, an average of 1 year
incidence of lung cancer
Interested in participating?
Request InfoSeoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07284459
Fibrosis, Idiopathic Pulmonary Fibrosis
Rosario, Santa Fe Province, Argentina
View Trial DetailsNCT07516951
Idiopathic Pulmonary Fibrosis, Lung Diseases
Skopje, North Macedonia
View Trial DetailsNCT07687459
Idiopathic Pulmonary Fibrosis, Lung Diseases
Hefei, Anhui, China
View Trial DetailsNCT05382572
Fibrosis, Idiopathic Pulmonary Fibrosis
Chicago, Illinois, United States
View Trial Details